TherapeuticsMD, Inc. short interest in 2023
In 2023, TherapeuticsMD, Inc.'s disclosed short interest ran from 3.42% of shares outstanding on 13 Jan 2023 to 2.04% on 29 Dec 2023, a change of -1.38 percentage points. The year's high was 3.67% on 14 Jul 2023 and its low 0.84% on 15 Dec 2023, averaging 2.87% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.11 days on 14 Jul 2023. Full history: TherapeuticsMD, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 3.42% (13 Jan 2023)
- End of year
- 2.04% (29 Dec 2023)
- Change
- -1.38 pp
- High
- 3.67% (14 Jul 2023)
- Low
- 0.84% (15 Dec 2023)
- Average
- 2.87%
- Highest days to cover
- 21.11 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 3.42% | 5.21 | |
| 31 Jan 2023 | 3.00% | 5.12 | |
| 15 Feb 2023 | 2.84% | 9.70 | |
| 28 Feb 2023 | 2.52% | 8.96 | |
| 15 Mar 2023 | 2.79% | 7.34 | |
| 31 Mar 2023 | 3.35% | 7.10 | |
| 14 Apr 2023 | 3.32% | 15.58 | 10-K filed, results (8-K) |
| 28 Apr 2023 | 3.44% | 9.25 | |
| 15 May 2023 | 3.14% | 5.07 | 10-Q filed, results (8-K) |
| 31 May 2023 | 2.96% | 12.85 | |
| 15 Jun 2023 | 3.01% | 8.69 | |
| 30 Jun 2023 | 3.66% | 10.59 | |
| 14 Jul 2023 | 3.67% | 21.11 | |
| 31 Jul 2023 | 3.38% | 17.84 | |
| 15 Aug 2023 | 3.03% | 15.27 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.88% | 14.73 | |
| 15 Sep 2023 | 3.49% | 16.75 | |
| 31 Oct 2023 | 2.35% | 12.71 | |
| 15 Nov 2023 | 2.02% | 11.37 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 1.94% | 8.56 | |
| 15 Dec 2023 | 0.84% | 2.84 | |
| 29 Dec 2023 | 2.04% | 7.46 |
See also: TherapeuticsMD, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.